Beiersdorf's newly built, state-of-the-art Innovation Center is located in Florham Park, N.J. Only 35 miles west of New York City, this area of New Jersey is considered a "science hotbed", as it is also home to other large research and development centers, and has excellent access to talent and universities, suppliers, and testing institutes. This N.J. Innovation Center is one of two regional Innovation Centers of Beiersdorf in the world; the other in Shanghai. It is the first global center of excellence for over-the-counter and sun care products outside of Hamburg.

"The Beiersdorf Innovation Center will be our powerhouse in North America," said Beiersdorf CEO Vincent Warnery. "The US represents the world's largest skin and sun care markets. A strong R&D presence in North America and an enhanced position in skin and sun care is vital to growing our business in the region and fully pays into our C.A.R.E.+ strategy."

Beiersdorf's Research & Development division sets industry-wide global standards on formulating, analyzing, and evaluating the effectiveness of skin care products, thanks to more than 900 scientists globally in the Consumer Business segment, including 45 in the new US facility. "Regional Innovation Centers are a vital part of our global R&D strategy. With this new center we significantly enhance our R&D capabilities, allowing us to accelerate innovation as well as to facilitate close collaboration with our local partners. It therefore enables us to fuse and fully leverage internal and external skin expertise in order to identify unmet patient and consumer needs, and to develop innovative, therapeutic skin care products," said Dr. Gitta Neufang, Corporate Senior Vice President Global R&D. Apart from the two regional Innovation Centers in China and the US, Beiersdorf has regional development labs in Brazil, India, Japan, and Mexico.

The new LEED-certified center in New Jersey spans about 3,000 m2 of office and laboratory space with room for expansion, and includes collaboration spaces, a consumer sensory panel focus room, and state-of-the-art GMP laboratory suites for the development of OTC products.

Attachments

  • Original Link
  • Original Document
  • Permalink

Disclaimer

Beiersdorf AG published this content on 03 February 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 03 February 2022 13:10:10 UTC.